| abstract |
The invention relates to the use of eletriptan, or a pharmaceutically acceptable salt or composition thereof, for the manufacture of a medicament for the prevention of migraine recurrence and to the use of a 5-HT 1B/1D receptor agonist, or a pharmaceutically acceptable salt or composition thereof, for the manufacture of a medicament of a dual-, sustained, delayed-, controlled- or pulsed-release pharmaceutical composition for the prevention of migraine recurrence. |